Literature DB >> 1141734

Porphyrin synthesis and mitochondrial respiration in acute intermittent porphyria: studies using cultured human fibroblasts.

H L Bonkowsky, D P Tschudy, E C Weinbach, P S Ebert, J M Doherty.   

Abstract

The formation of variation of delta-aminolevulinic acid (ALA) and of porphyrins, as well as respiratory metabolism, have been studied in skin fibroblasts from six normal control subjects and seven patients with acute intermittent porphyria. The mean activity of ALA synthetase was the same in both groups, whereas the mean activity of uroporphyrinogen I synthetase (as measured by the conversion of porphobilinogen [PBG] to porphyrins) was significantly decreased in fibroblasts from porphyric subjects, the mean value being 52 per cent that of control subjects (p less than or equal to 0.001). The findings of decreased uroporphyrinogen synthesis without an increase in ALA synthetase in mitochondria-containing cells from subjects with acute intermittent porphyria are compatible with the concept that defective PBG ultilization is the fundamental defect in heme biosynthesis in this disease and the possibility that ALA synthetase is "irreversibly" repressed in nonhepatic tissues. Respiration of the cells was studied polarographically. The two types of cells showed similar overall rates of respiration and in general responded to substrates and inhibitors as expected. Of the inhibitors tested (rotenone, amytal, antimycin, and cyanide), only rotenone showed a differential effect: respiration of fibroblasts from porphyric patients was not as sensitive to the inhibitor as was that of the control subjects. These results are interpreted as suggesting a possible defect in mitochondrial NADH oxidation in acute intermittent porphyria.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1141734

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  14 in total

1.  Perspectives in acute intermittent porphyria.

Authors:  I C Verma; S Singh
Journal:  Indian J Pediatr       Date:  1976-07       Impact factor: 1.967

2.  Study of factors causing excess protoporphyrin accumulation in cultured skin fibroblasts from patients with protoporphyria.

Authors:  J R Bloomer; D A Brenner; M J Mahoney
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

3.  Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias.

Authors:  Natalia Dixon; Ting Li; Brandon Marion; Denise Faust; Stephen Dozier; Anthony Molina; Sean Rudnick; Herbert L Bonkovsky
Journal:  Mol Genet Metab       Date:  2019-05-20       Impact factor: 4.797

4.  Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase.

Authors:  J M Lamon; B C Frykholm; D P Tschudy
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

5.  Characterization of the porphobilinogen deaminase deficiency in acute intermittent porphyria. Immunologic evidence for heterogeneity of the genetic defect.

Authors:  P M Anderson; R M Reddy; K E Anderson; R J Desnick
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

6.  Delta-Aminolaevulinic acid and amino acid neurotransmitters.

Authors:  M J Brennan; R C Cantrill
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

7.  Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.

Authors:  S Sassa; G L Zalar; A Kappas
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

8.  delta-Aminolevulinic acid effects on neuronal and glial tumor cell lines.

Authors:  L Helson; S Braverman; J Mangiardi
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

9.  Further evidence for the participation of 5 beta-steroids in the development of a porphyria induced by hexachlorobenzene.

Authors:  V Graef; S W Golf; C Tyrell
Journal:  Arch Toxicol       Date:  1982-09       Impact factor: 5.153

10.  Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts.

Authors:  H L Bonkowsky; J R Bloomer; P S Ebert; M J Mahoney
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.